News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GTCR Completes the Sale of Ovation Pharmaceuticals to Lundbeck Inc. (formerly Ovation Pharmaceuticals)



3/19/2009 8:46:06 AM

CHICAGO--(BUSINESS WIRE)--GTCR, one of the nation’s leading private equity firms, announced today that it has completed the previously announced sale of Ovation Pharmaceuticals, Inc. (Ovation), a leading U.S. biopharmaceutical company. Ovation was acquired by H. Lundbeck A/S (Lundbeck), an international pharmaceutical company based in Copenhagen, Denmark. The all-cash transaction will include payments of up to $900 million.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES